REST Restore Medical (MM)

Restore Medical, Inc. (NASDAQ:REST), developer of the innovative Pillar� Palatal Implant System � a simple, minimally-invasive treatment for individuals suffering from snoring and mild-to-moderate obstructive sleep apnea (OSA) � today announced that Bob Paulson, Restore Medical�s President and CEO, will present at the C.E. Unterberg, Towbin Life Sciences Conference on Tuesday, October 31, 2006, at 9:30 AM Eastern Time. The conference will be held at the Palace Hotel in New York City from October 30 through October 31, 2006. Individuals may listen to a live web cast of the presentation by logging on to the Investor Relations section of Restore�s web site www.restoremedical.com a few minutes prior to start time to download any necessary software. The C.E. Unterberg, Towbin Life Sciences Conference will feature representatives from 95 emerging growth companies from biotechnology, medical technology, drug delivery and specialty pharmaceuticals sectors. About Restore Medical and the Pillar Procedure Restore Medical develops, manufactures and markets innovative medical devices to treat sleep-disordered breathing. The Company�s proprietary Pillar� Palatal Implant System is the only implantable palatal device to treat snoring and mild-to-moderate obstructive sleep apnea to be approved by the U.S. Food and Drug Administration and Health Canada, and to have received the CE Mark for sale in the European Union. The Pillar Palatal Implant System is sold throughout the U.S. and Canada, and in various countries in Asia Pacific, Europe, South America and the Middle East. For more information about Restore Medical, the Pillar Procedure and physicians who offer the Pillar Procedure, visit the Company's website at www.restoremedical.com or www.pillarprocedure.com. Restore Medical, Inc. (NASDAQ:REST), developer of the innovative Pillar(R) Palatal Implant System - a simple, minimally-invasive treatment for individuals suffering from snoring and mild-to-moderate obstructive sleep apnea (OSA) - today announced that Bob Paulson, Restore Medical's President and CEO, will present at the C.E. Unterberg, Towbin Life Sciences Conference on Tuesday, October 31, 2006, at 9:30 AM Eastern Time. The conference will be held at the Palace Hotel in New York City from October 30 through October 31, 2006. Individuals may listen to a live web cast of the presentation by logging on to the Investor Relations section of Restore's web site www.restoremedical.com a few minutes prior to start time to download any necessary software. The C.E. Unterberg, Towbin Life Sciences Conference will feature representatives from 95 emerging growth companies from biotechnology, medical technology, drug delivery and specialty pharmaceuticals sectors. About Restore Medical and the Pillar Procedure Restore Medical develops, manufactures and markets innovative medical devices to treat sleep-disordered breathing. The Company's proprietary Pillar(R) Palatal Implant System is the only implantable palatal device to treat snoring and mild-to-moderate obstructive sleep apnea to be approved by the U.S. Food and Drug Administration and Health Canada, and to have received the CE Mark for sale in the European Union. The Pillar Palatal Implant System is sold throughout the U.S. and Canada, and in various countries in Asia Pacific, Europe, South America and the Middle East. For more information about Restore Medical, the Pillar Procedure and physicians who offer the Pillar Procedure, visit the Company's website at www.restoremedical.com or www.pillarprocedure.com.